Intervenolin, a new antitumor compound with anti-Helicobacter pylori activity, from Nocardia sp. ML96-86F2

被引:0
|
作者
Manabu Kawada
Hiroyuki Inoue
Shun-ichi Ohba
Masaki Hatano
Masahide Amemiya
Chigusa Hayashi
Ihomi Usami
Hikaru Abe
Takumi Watanabe
Naoko Kinoshita
Masayuki Igarashi
Tohru Masuda
Daishiro Ikeda
Akio Nomoto
机构
[1] Institute of Microbial Chemistry (BIKAKEN),
[2] Numazu,undefined
[3] Microbial Chemistry Research Foundation,undefined
[4] Laboratory of Disease Biology,undefined
[5] Institute of Microbial Chemistry (BIKAKEN),undefined
[6] Microbial Chemistry Research Foundation,undefined
[7] Laboratory of Synthetic Organic Chemistry,undefined
[8] Institute of Microbial Chemistry (BIKAKEN),undefined
[9] Microbial Chemistry Research Foundation,undefined
来源
关键词
antitumor drug; natural compound; tumor–stromal cell interactions;
D O I
暂无
中图分类号
学科分类号
摘要
Because stromal cells can regulate the growth and metastasis of tumor cells, a compound that modulates the interaction between the stromal cells and the tumor cells can control the tumor progression. In the course of our screening for such a compound, we have isolated a new compound, intervenolin, from the culture broth of Nocardia sp. ML96-86F2. Intervenolin inhibits the growth of human gastric and colorectal cancer cell lines in the coculture with the respective organ-derived stromal cells more strongly than that of the cancer cells cultured alone. Intervenolin shows antitumor effect against a xenograft model of human colorectal cancer cells in vivo. Furthermore, intervenolin exerts selective anti-Helicobacter pylori effect.
引用
收藏
页码:543 / 548
页数:5
相关论文
共 26 条
  • [1] Intervenolin, a new antitumor compound with anti-Helicobacter pylori activity, from Nocardia sp ML96-86F2
    Kawada, Manabu
    Inoue, Hiroyuki
    Ohba, Shun-ichi
    Hatano, Masaki
    Amemiya, Masahide
    Hayashi, Chigusa
    Usami, Ihomi
    Abe, Hikaru
    Watanabe, Takumi
    Kinoshita, Naoko
    Igarashi, Masayuki
    Masuda, Tohru
    Ikeda, Daishiro
    Nomoto, Akio
    JOURNAL OF ANTIBIOTICS, 2013, 66 (09): : 543 - 548
  • [2] Structure-activity relationship study of intervenolin derivatives: synthesis, antitumor, and anti-Helicobacter pylori activities
    Abe, Hikaru
    Kawada, Manabu
    Inoue, Hiroyuki
    Ohba, Shun-ichi
    Masuda, Tohru
    Hayashi, Chigusa
    Igarashi, Masayuki
    Nomoto, Akio
    Watanabe, Takumi
    Shibasaki, Masakatsu
    TETRAHEDRON, 2013, 69 (36) : 7608 - 7617
  • [3] SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIP STUDY OF INTERVENOLIN, AN ANTITUMOR AND ANTI-HELICOBACTER PYLORI QUINOLONE NATURAL PRODUCT
    Watanabe, Takumi
    HETEROCYCLES, 2021, 102 (10) : 1894 - 1937
  • [4] Antitumor effects of intervenolin, a novel natural compound with anti-Helicobacter pylori activity, and its synthetic derivatives on gastric and colorectal cancer cells.
    Kawada, Manabu
    Inoue, Hiroyuki
    Ohba, Shun-ichi
    Abe, Hikaru
    Hatano, Masaki
    Amemiya, Masahide
    Hayashi, Chigusa
    Usami, Ihomi
    Watanabe, Takumi
    Igarashi, Masayuki
    Masuda, Tohru
    Shibasaki, Masakatsu
    Nomoto, Akio
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [5] Anti-Helicobacter pylori Activity of a Lactobacillus sp. PW-7 Exopolysaccharide
    Hu, Jingfei
    Tian, Xueqing
    Wei, Tong
    Wu, Hangjie
    Lu, Jing
    Lyu, Mingsheng
    Wang, Shujun
    FOODS, 2021, 10 (10)
  • [6] YM-181741, a novel benz[a]anthraquinone antibiotic with anti-Helicobacter pylori activity from Streptomyces sp.
    Taniguchi, M
    Nagai, K
    Watanabe, M
    Niimura, N
    Suzuki, K
    Tanaka, A
    JOURNAL OF ANTIBIOTICS, 2002, 55 (01): : 30 - 35
  • [7] 3-farnesyl-2-hydroxybenzoic acid is a new anti-Helicobacter pylori compound from Piper multiplinervium
    Rüegg, T
    Calderón, AI
    Queiroz, EF
    Solís, PN
    Marston, A
    Rivas, F
    Ortega-Barría, E
    Hostettmann, K
    Gupta, MP
    JOURNAL OF ETHNOPHARMACOLOGY, 2006, 103 (03) : 461 - 467
  • [8] Pyloricidins, novel anti-Helicobacter pylori antibiotics produced by Bacillus sp.: I.: Taxonomy, fermentation and biological activity
    Nakao, M
    Miyagawa, K
    Nakano, Y
    Sakane, T
    Tada, M
    Nishimura, O
    Fujino, M
    JOURNAL OF ANTIBIOTICS, 2001, 54 (11): : 926 - 933
  • [9] New Silver(I) Coordination Compound Loaded into Polymeric Nanoparticles as a Strategy to Improve In Vitro Anti-Helicobacter pylori Activity
    Furquim de Camargo, Bruna Almeida
    Soares Silva, Debora Eduarda
    da Silva, Anderson Noronha
    Campos, Debora Leite
    Machado Ribeiro, Tamara Renata
    Mieli, Maria Julia
    Teixeira Zanatta, Melina Borges
    da Silva, Patricia Bento
    Pavan, Fernando Rogerio
    Moreira, Cristiano Gallina
    Resende, Flavia Aparecida
    Menegario, Amauri Antonio
    Chorilli, Marlus
    de Godoy Netto, Adelino Vieira
    Bauab, Tais Maria
    MOLECULAR PHARMACEUTICS, 2020, 17 (07) : 2287 - 2298
  • [10] New quinolone compounds from Pseudonocardia sp. with selective and potent anti-Helicobacter pylori activity:: Taxonomy of producing strain, fermentation, isolation, structural elucidation and biological activities
    Dekker, KA
    Inagaki, T
    Gootz, TD
    Huang, LH
    Kojima, Y
    Kohlbrenner, WE
    Matsunaga, Y
    McGuirk, PR
    Nomura, E
    Sakakibara, T
    Sakemi, S
    Suzuki, Y
    Yamauchi, Y
    Kojima, N
    JOURNAL OF ANTIBIOTICS, 1998, 51 (02): : 145 - 152